tiprankstipranks
Trending News
More News >

Pharvaris Announces Key Resolutions from Annual General Meeting

Story Highlights
Pharvaris Announces Key Resolutions from Annual General Meeting

Don’t Miss TipRanks’ Half-Year Sale

An update from Pharvaris ( (PHVS) ) is now available.

On June 27, 2025, Pharvaris N.V. held its Annual General Meeting of Shareholders, where key resolutions were passed. Shareholders adopted the Dutch statutory annual accounts for 2024, appointed PricewaterhouseCoopers as the auditor for 2025, and discharged directors from liability for 2024. Additionally, the board’s authorization to acquire shares was extended, and Dr. Meeker, Dr. Glassman, and Ms. Monges were re-appointed as non-executive directors. These decisions reflect the company’s commitment to maintaining strong governance and financial oversight, potentially bolstering stakeholder confidence.

The most recent analyst rating on (PHVS) stock is a Buy with a $31.00 price target. To see the full list of analyst forecasts on Pharvaris stock, see the PHVS Stock Forecast page.

Spark’s Take on PHVS Stock

According to Spark, TipRanks’ AI Analyst, PHVS is a Neutral.

Pharvaris exhibits significant financial difficulties, with no revenue and ongoing losses, resulting in a low financial performance score. Despite some technical momentum, the valuation is poor due to negative earnings. The stock’s overall score is affected by these financial and valuation challenges, despite its technical strength.

To see Spark’s full report on PHVS stock, click here.

More about Pharvaris

Pharvaris N.V. operates in the pharmaceutical industry, focusing on the development of innovative therapies for rare diseases. The company is primarily engaged in creating oral treatments for hereditary angioedema, a condition characterized by severe swelling attacks.

Average Trading Volume: 69,187

Technical Sentiment Signal: Buy

Current Market Cap: $956.9M

Learn more about PHVS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1